Sermorelin (general)

As you age, your body's natural hormone production, including human growth hormone (HGH) and HGH supplementation, begins to decline, contributing to the effects of aging. This can lead to symptoms like reduced energy, changes in body composition, and decreased vitality, prompting many to explore options like hormone replacement. One such option gaining attention is sermorelin therapy.

This article provides a comprehensive overview of sermorelin. We will explore what it is, its history, its current legal status, and how it works to stimulate your body's own hormone production. For adults with diagnosed growth hormone deficiency, the main benefits can include improved muscle mass, reduced body fat, better sleep, and increased energy levels.

We will also compare it directly to recombinant HGH (rhGH), discuss the evidence for its use in adults, and outline important safety considerations. Our goal is to give you a clear, guideline-anchored understanding of sermorelin therapy so you can have an informed discussion with your healthcare provider.

Sermorelin 101

Sermorelin is a substance known as a growth hormone-releasing hormone (GHRH) analog that stimulates HGH production. In simple terms, it is a synthetic peptide that mimics the function of the natural hormone your body uses to trigger the release of human growth hormone from the pituitary gland.

It is prescribed to address growth hormone deficiency by boosting your body's own hormone production capabilities. This makes sermorelin therapy a method of stimulation rather than direct replacement, which is a key distinction in how it functions within your system.

What is sermorelin?

At its core, sermorelin is a peptide made of the first 29 amino acids of human growth hormone-releasing hormone (GHRH). This specific structure allows it to effectively bind to receptors in your pituitary gland, signaling it to increase the natural production and secretion of HGH.

This type of treatment is known as peptide therapy. Unlike introducing a synthetic version of the final hormone (HGH) into your bloodstream, sermorelin works one step up the chain, prompting your body to do the work itself. This process helps maintain the natural, pulsatile rhythms of growth hormone release.

Compared to other growth hormone peptides, sermorelin's primary role is as a direct GHRH mimetic. Other peptides, like GHRPs (Growth Hormone Releasing Peptides), may work through different mechanisms or receptors to achieve a similar outcome, but sermorelin's action is specifically focused on replicating the body's natural GHRH signal.

History of use in growth hormone therapy

Sermorelin is not a new discovery. It was commercially manufactured and marketed for many years as a therapeutic agent under the brand name Geref. Its primary approved use was as a form of hormone therapy for children experiencing growth failure due to insufficient secretion of human growth hormone.

During this time, it was used to diagnose and treat these specific medical conditions. The therapy worked by stimulating the child's pituitary gland to produce its own growth hormone, thereby addressing the deficiency at its source and promoting natural growth.

This historical use established sermorelin as a legitimate medical treatment for GHD. Its mechanism has always been to increase growth hormone levels by acting as a secretagogue—a substance that causes another substance to be secreted—rather than as a direct replacement hormone.

Why it gained popularity as an alternative to rhGH

Sermorelin's popularity as an alternative to direct HGH supplementation and recombinant human growth hormone (rhGH) in adult hormone therapy stems from its fundamentally different and potentially safer mechanism of action. Because it stimulates your body's own production, it preserves natural physiological processes that rhGH bypasses.

Many clinicians consider sermorelin therapy safer than HGH therapy due to these inherent advantages. The body's natural feedback systems remain intact, which significantly reduces the risk of complications from excessive hormone levels. This leads to better safety profiles and fewer adverse effects.

Key advantages over rhGH include:

• Preserving Feedback Loops: Its effects are regulated by somatostatin, an inhibitory hormone, making an overdose of endogenous HGH nearly impossible.

• Simulating Natural Rhythms: It promotes an episodic release of HGH, avoiding the constant, unnatural "square wave" hormonal exposure caused by rhGH injections.

• Supporting Pituitary Health: It stimulates the pituitary gland, helping to preserve the entire growth hormone neuroendocrine axis, which is known to decline with age.

FDA status & why it was discontinued (not for safety)

It is crucial to understand the FDA status of sermorelin to appreciate its current place in medicine. Sermorelin was once an FDA-approved drug for growth hormone therapy in children. However, the commercial product was voluntarily withdrawn from the market by its manufacturer.

This discontinuation was not related to safety or efficacy concerns. Instead, it was a business decision. Understanding this history helps clarify why sermorelin therapy today is accessed through different channels than typical FDA-approved medications and avoids any unfounded legal risks associated with its use under prescription.

Original FDA approval in children with growth hormone deficiency

Sermorelin, under the brand name Geref, received its original FDA approval for a very specific purpose: the treatment of idiopathic growth hormone deficiency (GHD) in children. For this population, it was considered an effective form of hormone therapy to stimulate linear growth.

A good candidate for sermorelin therapy in that historical context was a child whose pituitary gland was healthy but was not receiving adequate stimulation to produce enough growth hormone. Sermorelin therapy acted as the missing signal, prompting the pituitary to release the HGH needed for normal development.

This approval validated its mechanism of action and established its legitimacy as a medical treatment. However, its use was narrowly defined for this pediatric population, and it was never formally approved by the FDA for use in adults with GHD or for anti-aging purposes.

Reasons it was discontinued (business, not safety)

The decision to discontinue the commercial production of sermorelin was based on business reasons, not on its safety profiles. In the competitive landscape of hormone therapy, sermorelin struggled to compete with recombinant human growth hormone (rhGH).

Paradoxically, the very reasons that make sermorelin a potentially better option for adults made it less competitive for its approved pediatric use. Children with significant growth deficiencies often require higher, more potent doses of growth hormone than what can be achieved by simply stimulating their own pituitary gland. Direct rhGH injections could deliver these higher levels more effectively.

As rhGH became the dominant treatment for pediatric GHD, the market for sermorelin shrank. The manufacturer ultimately found it was no longer commercially viable to produce, leading to its withdrawal from the market for these purely economic reasons.

Current legal status: compounded use in the U.S.

Although the FDA-approved commercial version of sermorelin is no longer available, the peptide can still be legally prescribed and used in the United States. Its current availability is through licensed compounding pharmacies, which prepare the medication on a per-prescription basis for individual patients.

This places sermorelin in a different regulatory status than rhGH. While the use of rhGH is federally restricted to specific, FDA-approved conditions, sermorelin is not a controlled substance and is not prohibited for off-label use in adults. A licensed physician can legally prescribe sermorelin for conditions like adult GHD.

This means there are fewer legal restrictions on a physician prescribing sermorelin therapy compared to HGH therapy for adults. However, it is crucial that it is obtained with a valid prescription from a qualified compounding pharmacy to ensure safety, purity, and legality, mitigating any potential legal risks.

How sermorelin works (vs rhGH)

The way sermorelin works is fundamentally different from that of recombinant human growth hormone (rhGH) and synthetic growth hormone. Sermorelin’s mechanism of action involves stimulation, whereas rhGH involves direct replacement. This is the central concept in this form of peptide therapy.

Instead of supplying your body with an artificial hormone, sermorelin prompts your pituitary gland to increase its own natural growth hormone release. This key difference has significant implications for the body's physiological response, safety, and overall effect of the therapy, which we will explore next.

Mechanism of action: stimulating natural GH release

Sermorelin works to increase growth hormone levels by mimicking the body's own growth hormone-releasing hormone (GHRH). When administered, this peptide travels to the pituitary gland and binds to specific GHRH receptors, effectively tricking the gland into believing the body is signaling for more HGH, which can also promote improvements in lean body mass, making it an important part of an effective treatment.

This binding action triggers a cascade of events within the pituitary gland, leading to the synthesis and secretion of your own natural growth hormone. This mechanism of action respects and utilizes the body's existing hormonal pathways rather than overriding them.

The process of stimulating natural growth hormone production has several key features:

• It directly prompts the pituitary gland to release stored HGH.

• It stimulates pituitary gene transcription, which can increase the gland's reserve capacity over time.

• The release is pulsatile, mimicking the body's natural, episodic secretion patterns.

• It is subject to the body’s negative feedback controls, preventing runaway production.

Key differences compared to recombinant human growth hormone (rhGH)

The key differences between sermorelin and rhGH are critical to understand when considering growth hormone therapy. While both aim to raise HGH levels, their methods, safety profiles, and physiological impacts are distinct. Sermorelin is a stimulator, while rhGH is a direct replacement with an artificial hormone.

This comparison of effectiveness and safety often favors sermorelin for long-term use in adults due to its more natural action. The direct administration of rhGH bypasses the body's regulatory systems, which can lead to a higher risk of side effects and hormonal imbalances.

Here is a table outlining the key differences:

Potential advantages of stimulating vs. replacing GH

Stimulating your body's natural production of growth hormone holds several potential advantages over direct hormone replacement therapy for effective weight management and cardiovascular health. This approach is generally considered safer because it works in harmony with your body's intricate endocrine system, rather than forcing a hormonal change upon it.

One of the most significant benefits is the preservation of negative feedback loops. When your HGH and IGF-1 levels rise, your body naturally releases somatostatin to halt further production. Sermorelin is subject to this safety mechanism, which helps prevent your hormone levels from becoming dangerously high and minimizes potential risks.

In contrast, injecting rhGH overrides this system entirely. This can lead to persistently elevated HGH levels, creating what one study calls "unnatural conditions of exposure" that may increase the risk of side effects like fluid retention, joint pain, and insulin resistance. By promoting natural production, sermorelin supports a more balanced and safer physiological state.

Evidence snapshot in adults (what’s known/limited)

When considering sermorelin for adult GHD, it's important to look at the existing evidence base. While promising, the clinical studies on sermorelin use in adults are not as extensive as those for rhGH. The research available suggests it can be effective for hormone therapy in this group.

However, the limitations of this evidence, such as smaller trial sizes and the lack of specific FDA approval for adults, must be acknowledged. This snapshot will explore what the current clinical studies show and where the gaps in our knowledge lie.

Studies on sermorelin in adult growth hormone deficiency (GHD)

Several clinical trials have investigated the efficacy of sermorelin as a hormone therapy for adults with GHD. While these studies are generally smaller than those for rhGH, they provide valuable insights into its potential benefits. The research consistently shows that sermorelin can effectively increase levels of both HGH and IGF-1 in adults.

One study published in Clinical Interventions in Aging highlighted sermorelin as a "better alternative to rhGH for GHRT in aging adults," pointing to its ability to simulate youthful hormone secretory dynamics. Source: Walker RF. Clin Interv Aging. 2006. This suggests its main benefits relate to restoring a more natural hormonal environment.

The findings from these clinical trials suggest that sermorelin can lead to:

• Significant increases in mean 24-hour GH levels.

• Restoration of HGH levels to a more youthful range.

• Improvements in physical and mental well-being.

• Favorable changes in body composition over time.

Benefits suggested: body composition, energy, sleep

The clinical evidence and patient reports suggest a range of benefits from sermorelin therapy, particularly in areas affected by age-related hormone decline. By restoring HGH levels, sermorelin can lead to noticeable improvements in body composition, including increased lean muscle mass and a reduction in body fat, which supports weight loss and enhances immune system function.

Beyond physical changes, many users report significant improvements, including a significant boost in their energy levels and enhanced sleep quality. Better sleep is a cornerstone of health, contributing to improved cognitive function, mood, and overall vitality. These effects are why sermorelin is often explored for anti-aging purposes, though this remains an off-label use.

Key suggested benefits include:

• Improved Body Composition: Supports fat loss and helps build or maintain lean muscle mass.

• Increased Energy Levels: Combats the fatigue often associated with GHD.

• Enhanced Sleep Quality: Promotes deeper, more restorative sleep cycles.

• Better Skin Health: May improve skin elasticity and texture.

Limitations of current evidence (small trials, lack of FDA adult approval)

While sermorelin shows promise, it is essential to have realistic expectations shaped by the limitations of the current evidence. The primary limitation is the lack of a specific FDA approval for adult GHD, which means it has not undergone the large-scale, rigorous clinical trials required for such an indication.

Most of the existing studies on sermorelin in adults are relatively small. This makes it difficult to draw definitive, universally applicable conclusions about its long-term efficacy and safety across diverse populations. The evidence we have is positive but not as robust as the data for rhGH.

Adults considering this therapy should be aware of these limitations:

• The evidence base is built on smaller clinical trials.

• It lacks formal FDA approval for use in adults.

• Long-term data on outcomes in adults is less extensive than for rhGH.

• Results may be more gradual and subtle compared to direct HGH injections.

Who might be evaluated (adult GHD) — guideline anchors

Determining who is a candidate for sermorelin therapy begins with a proper medical evaluation for adult growth hormone deficiency (GHD). This process is not based on symptoms alone but is guided by established diagnostic criteria and clinical guidelines from authoritative bodies like the Endocrine Society.

A thorough evaluation is necessary to confirm a true deficiency and rule out other potential causes for symptoms. Following these guideline anchors ensures that treatment is medically appropriate, safe, and necessary for the individual's health.

When to suspect adult growth hormone deficiency

Suspecting adult GHD often starts with recognizing a pattern of specific symptoms and clinical signs that align with low hormone levels. While these symptoms can be caused by other conditions, their presence together may warrant a conversation with your doctor about a potential deficiency.

A good candidate for evaluation is an adult who experiences a combination of these issues without another clear explanation. These symptoms often include a noticeable decline in physical and mental well-being that impacts quality of life.

Key signs and symptoms that might lead to suspecting adult GHD are:

• Increased body fat, particularly around the abdomen.

• Decreased muscle mass and strength.

• Persistent fatigue and low energy levels.

• Reduced bone density (osteopenia or osteoporosis).

• Impaired psychological well-being, including poor memory or mood.

Diagnostic testing: IGF-1 and stimulation tests

Before starting sermorelin, a formal diagnosis of growth hormone deficiency is essential, which requires specific diagnostic testing. The initial step is typically a blood test to measure the level of Insulin-like Growth Factor 1 (IGF-1). Since HGH levels fluctuate throughout the day, IGF-1 provides a more stable and reliable indicator of average HGH secretion.

If your IGF-1 levels are low or at the low end of the normal range for your age, your doctor may recommend a GH stimulation test. This is considered the gold standard for confirming a diagnosis. During a stimulation test, you are given a substance that should trigger a strong HGH release from your pituitary gland.

Your blood is then drawn at several intervals to measure the response. A failure to produce a sufficient amount of HGH confirms the diagnosis of growth hormone deficiency. This rigorous testing ensures that therapy is only given to those who medically require it.

Endocrine Society guidelines on adult GHD therapy

The Endocrine Society provides comprehensive clinical practice guidelines for the diagnosis and treatment of adult GHD. These guidelines are a critical resource for physicians, ensuring that hormone therapy is administered responsibly and based on sound scientific evidence.

The guidelines emphasize the importance of using strict diagnostic criteria. This includes a high likelihood of GHD based on medical history (like a pituitary tumor or cranial irradiation) combined with a definitive result from a GH stimulation test. They advise against making a diagnosis based on a single low IGF-1 measurement alone.

Crucially, the Endocrine Society underscores that all hormone therapy for GHD must be conducted under careful medical supervision. This includes initial diagnostic testing, individualized dosing, and regular monitoring to assess benefits and check for potential side effects, ensuring patient safety throughout the treatment.

Safety & side effects; sourcing/compounding considerations

While sermorelin has favorable safety profiles, it is not without potential side effects. Understanding these is a key part of making an informed decision. Equally important is the issue of sourcing. Since it is prepared by compounding pharmacies, quality and purity are major considerations.

Choosing a reputable source is essential for minimizing health and legal risks. Unregulated products can pose a significant danger, making the partnership between you, your doctor, and a trusted pharmacy critical for a safe treatment experience.

Common side effects (injection site, flushing, headache)

Sermorelin is generally well-tolerated, but like any medication, it can cause side effects. The most common adverse effects are related to the injection itself. These reactions are typically mild and resolve on their own within a few days.

Other systemic side effects, including carpal tunnel syndrome, can occur as your body adjusts to changes in hormone levels but are less frequent. Compared to direct HGH therapy, side effects like significant fluid retention and joint pain are reported much less often with sermorelin.

Common side effects of sermorelin treatment may include:

• Injection site reactions: Redness, pain, itching, or swelling at the spot of the subcutaneous injection.

• Flushing: A temporary feeling of warmth in the face and neck.

• Headache: Mild headaches can sometimes occur after an injection.

• Nausea or dizziness: Some individuals may experience a lightheaded or queasy feeling.

Why sourcing matters: compounding pharmacies and quality concerns

Sourcing sermorelin from a reliable and licensed U.S. compounding pharmacy is paramount for your safety. Because sermorelin is not mass-produced by a pharmaceutical company, its quality, purity, and sterility depend entirely on the standards of the pharmacy that prepares it.

Reputable compounding pharmacies are subject to strict state and federal regulations to ensure their products are safe and accurately formulated. Bypassing these channels introduces significant quality concerns. You have no guarantee of the product's identity, strength, or purity, which directly impacts its safety profiles and effectiveness.

While a doctor can legally prescribe sermorelin from a compounding pharmacy, purchasing it from an unverified source carries potential legal risks. Using a trusted pharmacy ensures you are receiving a legitimate medical product in compliance with the law, protecting both your health and legal standing.

Legal risks of unregulated online products

Purchasing sermorelin from unregulated online websites presents serious legal risks and even greater health dangers. These products are sold outside the legal framework that requires a doctor's prescription and a licensed pharmacy. This practice is illegal and bypasses all safety checks.

The potential risks associated with these unregulated products are substantial. There are widespread quality concerns, as these substances may be counterfeit, contaminated with harmful ingredients, incorrectly dosed, or not sterile, which can lead to severe infections or other adverse health outcomes.

When considering sermorelin or HGH therapy, be aware of the following risks with unregulated sources:

• Health Dangers: Products may be contaminated, inactive, or improperly dosed.

• Legal Consequences: Buying prescription medication without a valid prescription is illegal.

• Lack of Medical Supervision: Using these products without a doctor's guidance is unsafe.

• Financial Loss: You may be paying for a useless or dangerous substance.

The bottom line & next steps

The bottom line is that sermorelin therapy offers a distinct alternative to direct HGH replacement, working with your body’s natural systems. Understanding the key differences in mechanism, safety, and evidence is the first step toward making an informed choice.

The most important next step is seeking professional medical supervision. A discussion with a qualified healthcare provider is the only way to explore safe options, determine if you are a candidate, and ensure your health is the top priority.

What sermorelin can and can’t offer adults

It's vital for adults to have realistic expectations about what sermorelin therapy can and cannot do. For individuals with a confirmed diagnosis of adult GHD, sermorelin can offer gradual, meaningful improvements in energy, body composition, sleep quality, and overall well-being by helping to restore hormone levels to a more youthful state.

However, sermorelin is not a "fountain of youth" or a quick fix. The expected outcomes are more subtle and develop over several months of consistent use. It cannot reverse the aging process, and its effects may not be as dramatic or rapid as those seen with high-dose rhGH injections.

Understanding these limitations is key. The goal of sermorelin therapy is to support your body's natural function and alleviate the specific symptoms of GHD, leading to a better quality of life. It is a medical treatment, not a miracle cure.

Why a medical evaluation is essential

A comprehensive medical evaluation is a non-negotiable prerequisite for starting sermorelin therapy. Self-diagnosing based on symptoms is unreliable and potentially dangerous, as many conditions can mimic the signs of low hormone levels. Only a qualified healthcare provider can perform the necessary tests to reach an accurate diagnosis.

This evaluation is the only way to determine who is a good candidate for sermorelin. A physician will review your medical history, conduct a physical exam, and order blood work to confirm a growth hormone deficiency. This ensures that the treatment is medically necessary and appropriate for you.

Furthermore, medical supervision is essential for safety. A doctor will determine the correct dosage, monitor your progress, and manage any potential side effects. Proceeding without a professional medical evaluation puts your health at unnecessary risk.

Discussing safe options with your endocrinologist

Your next step should be to schedule a consultation with a hormone specialist, such as an endocrinologist. This expert is best equipped to discuss all safe options for addressing your concerns, whether they stem from aging, a hormone deficiency, or other specific medical conditions.

During your discussion, you can explore whether sermorelin is a suitable choice for your individual health profile and goals. For women, the potential benefits of sermorelin can be particularly relevant for managing age-related changes and promoting healthy aging, such as shifts in body composition, energy, and skin health during perimenopause and beyond. Your endocrinologist can tailor the conversation to your unique needs.

Ultimately, working with a specialist ensures that any treatment plan is developed under proper medical supervision. They can help you weigh the pros and cons of sermorelin versus other therapies, ensuring you make the safest and most effective choice for your long-term health.

Ask a Healthon clinician about appropriate testing and options

If you are experiencing symptoms that you believe may be related to a growth hormone deficiency, it is time to seek professional guidance. Discussing your concerns with a qualified clinician is the most reliable way to get answers and explore your options for growth hormone therapy safely. The clinicians at Healthon are available to help you navigate this process.

A Healthon clinician can discuss your symptoms, determine if you are a candidate for diagnostic testing, and explain what the evaluation entails. Based on your results and specific medical conditions, they can help you understand the full range of appropriate treatment options, including whether sermorelin therapy is right for you. Taking this step ensures your journey toward better health is guided by expertise and a commitment to your safety.

Conclusion

In summary, Sermorelin is a complex peptide that has garnered attention for its role in stimulating natural growth hormone release. Its journey from FDA approval to discontinued status, and now to compounded use, highlights the evolving landscape of hormone therapy. Understanding how it differs from recombinant human growth hormone is crucial for those considering its benefits and limitations. While evidence suggests potential positive effects on body composition and energy levels in adults, it’s important to approach this therapy with caution and professional guidance. For anyone interested in exploring their options or seeking personalized advice on testing and treatment, we encourage you to sign up for a consultation with a Healthon clinician. Your journey to understanding and improving your health begins with informed decisions.

Frequently Asked Questions

Is sermorelin legal in the U.S.?

Yes, sermorelin is legal in the U.S. with a valid prescription from a licensed doctor. Although its commercial FDA status was discontinued, it is not a controlled substance and can be legally prepared by compounding pharmacies for patients requiring growth hormone therapy.

What testing is needed before starting sermorelin?

Before starting sermorelin, a medical evaluation is required. This includes diagnostic testing, typically starting with a blood test to measure IGF-1 levels. If needed, a GH stimulation test may be performed to confirm a deficiency. This must be done under medical supervision.

How long does it take to see results with sermorelin?

Results from sermorelin therapy are gradual. Some benefits, like improved sleep, may appear within weeks. However, more significant changes in energy and fat metabolism, as well as body composition, including muscle growth, typically take 3 to 6 months of consistent use as your body's natural hormone production slowly increases.

What expectations should adults have with sermorelin therapy?

Adults with diagnosed GHD should expect gradual, subtle improvements in energy, sleep, and body composition. Sermorelin is one of several safe options for restoring hormone levels, but it is not a quick fix. Discuss expected outcomes with your doctor.

Why was sermorelin discontinued if it wasn’t for safety reasons?

Sermorelin was discontinued for commercial business reasons, not because of its safety profiles. It could not compete effectively with rhGH as a growth hormone therapy in the pediatric market, which led the manufacturer to cease its production.

Reference List

1. AgeWell Medicine. (n.d.). Sermorelin therapy overview. https://agewellmedicine.com/sermorelin
   
   

2. Blue Sky MD. (n.d.). Unlocking sermorelin benefits and hormone health. https://blueskymd.com/unlocking-sermorelin-benefits-and-hormone-health/
   
   

3. Genesis Lifestyle Medicine. (n.d.). Sermorelin vs. HGH: What is the difference?. https://www.genesislifestylemedicine.com/blog/sermorelin-vs-hgh-what-is-the-difference/
   
   

4. Get Heally. (n.d.). Is sermorelin safer than HGH? Legal and medical perspective. https://getheally.com/patients/news/is-sermorelin-safer-than-hgh-understanding-the-legal-and-medical-perspective
   
   

5. Healthline. (2023). Sermorelin: Uses and benefits. https://www.healthline.com/health/sermorelin
   
   

6. HydraMed. (2023). Sermorelin vs. HGH: Comparing peptide therapies. https://hydramed.com/blog/sermorelin-vs-hgh-comparing-peptide-therapies
   
   

7. Innerbody. (2023). Sermorelin therapy guide. https://www.innerbody.com/sermorelin
   
   

8. NHM Wellness. (n.d.). Sermorelin injections. https://nhmwellness.com/sermorelin-injections/
   
   

9. PMC. (2006). Growth hormone secretagogues and aging. Clinical Interventions in Aging. https://pmc.ncbi.nlm.nih.gov/articles/PMC2699646/
   
   

10. PMC. (2006). Sermorelin as a GHRH analog for adults. https://pmc.ncbi.nlm.nih.gov/articles/PMC2699646/?utm_source=chatgpt.com
    
    

11. Prime Aesthetica. (2023). Sermorelin injections overview. https://www.primeaesthetica.com/blog/sermorelin-injections.html
    
    

12. Regenics. (2023). Sermorelin vs. HGH: Key differences and benefits explained. https://regenics.com/sermorelin-vs-hgh-key-differences-and-benefits-explained/
    
    

13. Rejuvime Medical. (2023). Sermorelin HGH therapy. https://rejuvimemedical.com/blog/sermorelin-hgh-therapy-baton-rouge/
    
    

14. Swolverine. (2023). Sermorelin acetate: How it compares to other GH peptides. https://swolverine.com/blogs/blog/sermorelin-acetate-what-it-is-and-how-it-compares-to-other-gh-peptides?srsltid=AfmBOoo38pN2W13bfWTxkoyTjUVQS5XqKAfDXbFaOdrgttI2yjxJ0XlL
    
    

15. Join Midi. (2023). Sermorelin benefits overview. https://www.joinmidi.com/post/sermorelin-benefits